Showing results (91-100 of 196) with videos related to
Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|May 20, 2015
Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy VolunteersSang-In Park, Jaeseong Oh, Kyungho Jang, et al.Scientific Reports|August 31, 2019
Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosisSongYi Han, Yeon Joo Lee, Jong Sun Park, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|March 28, 2018
Bronchoscopic Improvement of Tracheobronchitis Due to Methicillin-Resistant Staphylococcus aureus After Aerosolized Vancomycin: A Case SeriesJun Yeun Cho, Youlim Kim, Sang Hoon Lee, et al.The Korean Journal of Internal Medicine|July 23, 2021
Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort studyHyeontaek Hwang, Jung-Kyu Lee, Sun Mi Choi, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 17, 2015
Factors associated with preserved pulmonary function in non-small-cell lung cancer patients after video-assisted thoracic surgerySe Joong Kim, Soyeon Ahn, Yeon Joo Lee, et al.Plos One|July 26, 2018
Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosisSooim Sin, Kyung Hee Lee, Jee Hye Hur, et al.Endoscopic Ultrasound|April 6, 2026
Long-term prognosis and risk factor-based surveillance strategy for patients with small gastric subepithelial lesion using endoscopic ultrasonographyJong Sun Park, Ji Hyun Park, Bumhee Park, et al.Advances in Therapy|April 17, 2020
Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean PatientsMan Pyo Chung, Moo Suk Park, In Jae Oh, et al.In Vivo (Athens, Greece)|June 27, 2025
Role of Emergent Endoscopic Evaluation for Corrosive Injuries: Should We Do It or Not?Ji Hyun Kim, Ji Min Kim, Bumhee Park, et al.International Journal of Molecular Medicine|November 15, 2011
Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitorsDal Rae Kim, Mi-Young Park, Hyo-Jeong Lim, et al.Pageof 20